|
US2016243045A1
|
|
Dosage forms for administering combinations of drugs
|
|
US2014141080A1
|
|
Pharmaceutical compositions for the coordinated delivery of NSAIDs
|
|
EA028049B1
|
|
Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid
|
|
MX2014003216A
|
|
Controlled dosing of clopidogrel with gastric acid inhibition therapies.
|
|
EP2755979A1
|
|
Phased dosing of clopidogrel
|
|
TN2011000662A1
|
|
Method for treating a patient at risk for developing an nsaid-associated ulcer
|
|
WO2010151697A1
|
|
Method for treating a patient in need of aspirin therapy
|
|
WO2009145905A1
|
|
Dosage forms for the rapid and sustained elevation of gastric ph
|
|
EA020867B1
|
|
Dosage forms for administering combinations of drugs
|
|
US2006178349A1
|
|
Compositions and therapeutic methods utilizing a combination of a 5-HT1F inhibitor and an NSAID
|
|
WO2006081088A2
|
|
Compositions and therapeutic methods utilizing a combination of a protein extravasation inhibitor and an nsaid
|
|
US2006178348A1
|
|
Compositions and therapeutic methods utilizing a combination of a protein extravasation inhibitor and an NSAID
|
|
EP1841409A2
|
|
Dosage form for treating gastrointestinal disorders
|
|
US2006165797A1
|
|
Dosage form for treating gastrointestinal disorders
|
|
US2004180089A1
|
|
Multilayer dosage forms containing NSAIDs and triptans
|
|
US2003232876A1
|
|
Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
|
|
EP2260837A1
|
|
Pharmaceutical compositions for the coordinated delivery of NSAIDs
|
|
US6586458B1
|
|
Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
|
|
IL145550D0
|
|
High potency dihydroergotamine compositions
|
|
WO0048583A2
|
|
Formulation of 5-ht agonists with nsaids, especially cox-2 inhibitors, for treating migraine
|
